CurveBeam AI (ASX:CVB) Receipts from Customers: A$11.79 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is CurveBeam AI Receipts from Customers?

CurveBeam AI ASX:CVB Receipts from Customers is A$11.79 Mil as of Dec. 2025. The stock has 5 warning signs investors should review.

CurveBeam AI's Receipts from Customers for the six months ended in Dec. 2025 was A$3.96 Mil.

CurveBeam AI's Receipts from Customers for the trailing twelve months (TTM) ended in Dec. 2025 was A$11.79 Mil.

CurveBeam AI Receipts from Customers Historical Data

* Premium members only.

The historical data trend for CurveBeam AI's Receipts from Customers can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CurveBeam AI Receipts from Customers Chart

CurveBeam AI Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Receipts from Customers
0.00 0.00 6.83 7.09 12.82

CurveBeam AI Semi-Annual Data
Jun21 Dec21 Jun22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Receipts from Customers Get a 7-Day Free Trial Premium Member Only 2.95 4.14 5.00 7.82 3.96

CurveBeam AI Receipts from Customers Calculation

A company's cash flow from operations for a time period can be determined using either the direct or indirect method. The indirect method modifies the operating section from accrual accounting to a cash basis by taking the net income generated in a period and adding or subtracting changes in the asset and liability accounts to determine the implied cash flow. However, the direct method uses actual cash inflows and outflows from the company's operations directly. Receipts from Customers represents payment received from customers in the direct cash flow method.

Receipts from Customers for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$11.79 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Receipts from Customers of A$11.79 Mil mean?
CurveBeam AI (ASX:CVB) has a Receipts from Customers of A$11.79 Mil as of Dec. 2025. Receipts from Customers represents payment received from customers in the direct cash flow method. View historical data for CurveBeam AI and its competitors.
Is CurveBeam AI's Receipts from Customers too high?
CurveBeam AI's current Receipts from Customers is A$11.79 Mil.
How does CurveBeam AI's Receipts from Customers compare to ABT and SYK?
CurveBeam AI's Receipts from Customers of A$11.79 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receipts from Customers for a Medical Devices & Instruments company?
A good Receipts from Customers depends on the Medical Devices & Instruments industry context. However, Receipts from Customers should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receipts from Customers mean?
A high Receipts from Customers can signal that a stock is expensive relative to its fundamentals. Receipts from Customers represents payment received from customers in the direct cash flow method. View historical data for CurveBeam AI and its competitors. CurveBeam AI's current Receipts from Customers is A$11.79 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CurveBeam AI stock overvalued right now?
CurveBeam AI (ASX:CVB) has a current Receipts from Customers of A$11.79 Mil. The current Receipts from Customers is A$11.79 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receipts from Customers calculated?
Receipts from Customers is calculated from a company's financial statements. For CurveBeam AI (ASX:CVB), the current Receipts from Customers is A$11.79 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CurveBeam AI Business Description

Address 10 Queen Street, Level 10, Melbourne, VIC, AUS, 3000
CurveBeam AI Ltd is a manufacturer of specialized imaging equipment that has developed software that, through the use of artificial intelligence (AI), and deep learning AI (DLAI), automates the scan processing and analysis of the high-quality images produced from the company's CT devices to assist in the clinical assessment. The company has one operating segment, being the research, design, manufacture and sale of cone beam CT imaging equipment for orthopaedic specialties, which includes the development, validation and preparation for commercialisation of a HRpQCT Medical Device and Software as a Service (SaaS) platform.